INBX - CIK 0001739614
The table below shows Inhibrx, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $252.48M | $337.33M | $192.49M | $234.25M | $146.07M | $176.38M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $171.00K | - | - | $304.00K | $243.00K | $243.00K |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $274.54M |
| $363.30M |
| $203.32M |
| $243.78M |
| $153.75M |
| $181.62M |
| Property, plant & equipment | $6.97M | $2.86M | $2.83M | $2.48M | $2.80M | $2.88M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $288.58M | $372.73M | $213.17M | $253.72M | $164.85M | $193.21M |
| Accounts payable | $14.79M | $7.86M | $9.70M | $10.92M | $8.57M | $9.25M |
| Total current liabilities | $71.87M | $35.77M | $31.33M | $32.64M | $25.43M | $24.20M |
| Long-term debt | $204.58M | - | - | - | - | - |
| Total liabilities | $277.01M | $243.14M | $237.98M | $238.58M | $199.90M | $198.13M |
| Retained earnings | -$692.44M | -$520.13M | -$468.34M | -$421.29M | -$331.46M | -$296.13M |
| Total equity | $11.57M | $129.59M | -$24.81M | $15.13M | -$35.05M | -$4.92M |